CIBC Asset Management Inc Grows Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY
CIBC Asset Management Inc grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 442.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,832 shares of the biopharmaceutical company’s stock after buying an additional 24,334 shares […]
6 Jun 07:27 · The Markets Daily